Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
Organisation › Details

Ascendis Pharma A/S (Nasdaq: ASND)

Ascendis Pharma is an emerging pharmaceutical company which is creating improved, patentable versions of both currently marketed drugs and high-value development-stage opportunities. The company is built upon a novel transient linker technology, which conjugates peptides, proteins and small molecules to a carrier molecule in a reversible fashion. This unique reversibility allows an unmodified active drug to be released (unlinked) in the body in a precise, time-controlled fashion, creating a long-acting effect. Conventional conjugation technologies are unable to achieve this type of slow-release mechanism because the polymer cannot de-link from the drug.

Ascendis’ commercial headquarters is based in Copenhagen, Denmark. Its research organization, formerly known as Complex Biosystems, is located in Heidelberg, Germany. The expertise at the two sites creates a continuum from discovery to clinical development and commercialization that facilitates rapid product development. *


Period Start 2007-12-01 established
  Group Ascendis Pharma (Group)
  Today Ascendis Pharma (Group)
Products Industry TransCon technology
  Industry 2 pharmaceutical
Persons Person Mikkelsen, Jan (Ascendis Pharma 201609 CEO)
  Person 2 Smith, Scott T. (Ascendis Pharma 201609 CFO)
Region Region Hellerup
  Country Denmark
  Street 12 Tuborg Boulevard
  City 2900 Hellerup
  Tel +45-3694-4486
    Address record changed: 2020-12-02
Basic data Employees D: 101 to 500 (2017-12-31)
  Currency EUR
  Annual sales 1,530,000 (revenue, consolidated (2017) 2017-12-31)
  Profit -123,897,000 (2017-12-31)
  Cash 690,400,000 (2019-06-30)
    * Document for �About Section�: 
Record changed: 2020-05-19


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Ascendis Pharma (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

» top